SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending sharply lower after the Trump administration proposed a near-flat 0.09% increase for Medicare Advantage payments in 2027, a move announced just hours before UNH's anticipated earnings report. This unexpected policy shift has ignited intense debate among investors, with many viewing it as a significant threat to future margins and further downside for healthcare insurers, while others believe the selloff is an overreaction or even a market manipulation designed to create a buying opportunity.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing intense community debate ahead of its anticipated earnings report. Bulls are optimistic, expecting a strong performance and potential S&P 500 inclusion, driven by institutional accumulation. However, many investors remain deeply frustrated by perceived market manipulation, previous share dilution, and a history of stagnant price action following positive earnings, leading to significant bearish sentiment.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is undergoing extreme volatility after reaching historic price levels, with community sentiment split between a potential short squeeze driven by massive industrial demand and de-dollarization narratives, and fears of a significant correction. Bulls celebrate "generational" gains and anticipate further upside from Asian buying and central bank interest, while bears see signs of a "blow-off top" and are actively attempting to short the pronounced price swings.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is currently trending as prominent investor Michael Burry has announced a new long position, emphasizing a belief in CEO Ryan Cohen's strategy to utilize the company's substantial cash reserves for long-term value rather than a short-term meme-stock play. This revelation, coupled with recent insider buying, has sparked intense community discussion and speculation about potential for significant upward momentum, with many anticipating a catalyst like a "gamma squeeze" or a return of the "Roaring Kitty" to reignite broader interest.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), Global Services (BGS), and Boeing Capital (BCC). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The Boeing Capital segment seeks to ensure that Boeing customers have the financing they need to buy and take delivery of their Boeing product and manages overall financing exposure. The company was founded by William Edward Boeing on July 15, 1916 and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is actively trending as the market anticipates its upcoming earnings report, with community focus on the company's progress in boosting production rates, advancing aircraft certifications, and delivering on free cash flow targets. Recent substantial order inflows and increased delivery figures are driving optimistic conversations around a potential turnaround, though some investors remain cautious about previous performance and the stock's strong run. The broader aerospace sector is closely watching management's outlook for sustained operational stabilization and future growth.

AABG Token

AABBG CRYPTO is trending as its parent company, AABB, generates significant buzz with an active federal lawsuit against market makers for alleged manipulation, alongside the highly anticipated launch of its new AABB Wallet and silver-backed AABBS token. The community remains fiercely bullish, citing substantial gold and silver holdings amid rising precious metal prices, believing the stock is undervalued and primed for a significant upward move.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is actively discussed as a Neutron Stage 1 tank rupture during hydrostatic testing divides the community: some see it as a normal part of pushing design limits, while others express concern over potential launch schedule impacts. Amidst this, the company's reliable Electron missions and substantial defense contracts continue to highlight its growing presence in the expanding space and national security sectors, maintaining a bullish outlook from many.

Pump.fun

PUMP is currently trending due to significant FUD stemming from legal issues, including a former developer's fraud conviction and a related lawsuit against the platform. While this has fueled price volatility and community concern, many users are viewing the downturn as a "bear trap" and an accumulation opportunity. The ongoing debate centers on the platform's long-term viability, given its dominant position as a Solana-based launchpad and reported consistent token buybacks.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

QCLS is drawing significant attention after appointing an OpenAI expert to its Board, propelling excitement around its quantum-class photonic computing strategy. The community is actively discussing the stock's potential for substantial movement, often comparing it to other high-flying microcap plays, while also weighing concerns about dilution and short interest dynamics. This places QCLS in a dynamic spotlight within the evolving AI and advanced computing landscape.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is trending due to a wave of strategic initiatives, including its aggressive global expansion, advancements in AI-driven autonomous driving with VLA 2.0, and diversification into robotics and flying cars. The community is actively discussing the company's severely undervalued status, anticipating that expected profitability and increasing international partnerships will serve as catalysts for a significant upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mitsubishi UFJ Trust & Banking Corp Sells 8,273 Shares of Alnylam Pharmaceuticals, Inc. $ALNY

Mitsubishi UFJ Trust & Banking Corp reduced its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 9.6% in the third quarter, according to its most recent filing with the...

Wealth Enhancement Advisory Services LLC Boosts Holdings in Alnylam Pharmaceuticals, Inc. $ALNY

Wealth Enhancement Advisory Services LLC grew its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 183.8% during the third quarter, according to its most recent filing...

Alnylam Pharmaceuticals Enters Oversold Territory (ALNY)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...

Top Pharmaceutical Stocks To Watch Now - January 23rd

Eli Lilly and Company, Abbott Laboratories, Novo Nordisk A/S, Gilead Sciences, Pfizer, AbbVie, and Alnylam Pharmaceuticals are the seven Pharmaceutical stocks to watch today, according to...

31,152 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Bought by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. bought a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) during the 3rd quarter, according to the company in its most recent filing with the...

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Lowered to $465.00 at Royal Bank Of Canada

Royal Bank Of Canada cut their price target on Alnylam Pharmaceuticals from $500.00 to $465.00 and set an "outperform" rating for the company in a report on Tuesday...

Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $376.00 Price Target at Wells Fargo & Company

Wells Fargo & Company cut their target price on shares of Alnylam Pharmaceuticals from $479.00 to $376.00 and set an "equal weight" rating for the company in a research note on Tuesday...

356,529 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Purchased by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA acquired a new position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) during the 3rd quarter, according to its most recent filing with the...

Allstate Corp Acquires Shares of 4,571 Alnylam Pharmaceuticals, Inc. $ALNY

Allstate Corp bought a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Donoghue Forlines LLC Takes $2.11 Million Position in Alnylam Pharmaceuticals, Inc. $ALNY

Donoghue Forlines LLC purchased a new position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the...

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

No change

25 bps cut

25 bps hike

Note sure, just watching

The Fed announces its rate decision this Wednesday.

Markets are pricing in a ~99% chance of no change at this week’s Fed decision, according to prediction markets. $SPY $QQQ 

FOMC on Wednesday, what do you think the Fed will decide?

ALNY
Alnylam Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ALNY News

ALNYAlnylam Pharmaceuticals Inc